Bios Partners

Fort Worth, United Statesbiospartners.com

Bios Partners is a venture capital firm based in Fort Worth, the United States, investing in Healthcare & Life Sciences, Medical Diagnostics and Medical Device, 1 tracked investment.

View Full Profile Website

Investments Tracked

See full portfolio →

About Bios Partners

Bios Partners is a venture capital firm headquartered in Fort Worth, the United States. We have recorded 1 investment for Bios Partners to date.

Sector activity concentrates in Healthcare & Life Sciences, Medical Diagnostics, Medical Device and Retinal Disease. Coverage extends to 8 sectors in total. Investments are concentrated at Series B.

BIOS Partners is a venture capital firm focused on investing in early-stage life science companies, primarily in the areas of biotechnology, pharmaceuticals, and medical devices. They seek to invest in companies with innovative technologies and strong management teams that address unmet medical needs.

Investment Focus

Stage Focus

series-b

Sectors

Healthcare & Life SciencesMedical Diagnosticsmedical-deviceretinal-diseaser-dhealthcaretherapeuticsvision-care

Investment Thesis

Bios Partners Portfolio Companies

2 tracked holdings.

Full portfolio →

ONL TherapeuticsUnited States Actuate TherapeuticsUnited States

Portfolio outcomes

10 active

Team

Aaron G.L. FletcherManaging Partner & Co-Founder

Dr. Fletcher is managing director of Bios Partners, a life sciences venture firm based in Fort Worth, Texas and founded and serves as president of Bios Research, a financial services firm that provides public equity research in the healthca…

Leslie W. Kreis, Jr.Managing Partner & Co-Founder

Kreis has over 25 years of investment experience across many types of financial instruments in both global public and private equity markets. Currently, he is the Managing Principal at Steelhead Capital Management, which manages a portfolio…

Stella M. RobertsonCo-founder and Partner

Dr. Robertson has over 25 years of experience in pharmaceutical Research and Development, including R&D strategies, project management, clinical trials, regulatory filings, product launch, market support, translational medicine, and medical…

John FucciPartner

John Fucci is a Partner at Bios Partners, a biotech venture capital firm based in Fort Worth, TX. Mr. Fucci focuses on diligence and negotiations of new investment opportunities, portfolio company management, and investor relations.

Amanda De La GarzaPartner

Ms. de la Garza has over five years’ experience in financial and scientific analysis as an analyst at Bios Research and Bios Partners. Ms. de la Garza has developed a strong understanding of healthcare market dynamics and commercial viabili…

Troy OsbornCFO

Mr. Osborn is the CFO at Bios Partners. Prior to starting with Bios Partners in June of 2019, Mr. Osborn worked as an auditor at KPMG LLP, specializing in private equity and hedge fund accounting.

Stephen PhillipsVice President

Stephen Phillips is the Vice President at Bios Partners. Mr. Phillips focuses on diligence and negotiations of new investment opportunities, portfolio company management, and investor relations.

Tim Van TreurenPrincipal of New Ventures

Dr. Van Treuren joined Bios Partners in 2019. Dr. Van Treuren manages deal flow, leads scientific due diligence on new opportunities, and supports portfolio companies. He currently serves on the board of Bobcat Bio.

Blake PateVice President of Investments

Blake Pate is Vice President of Investments at Bios Partners where he joined in May 2019. At Bios, Blake focuses on investment due diligence, deal flow, and frequently attends banking conferences and medical meetings.